February 27 2017
Congratulations! Michael has received his internship offer for the Air Force Research Laboratory in Florida.
February 21 2017
Congratulations! Yoshi has received his internship offer from Phenomyx, a biotechnology company. He will study a novel single-cell level high-throughput screening method to target cancer.
Dr. Kim has received the NSF CAREER AWARD, which recognizes the highest level of excellence among early-stage researchers, entitled, "CAREER: Integrated Microfluidic Systems for Scalable Manufacturing of Hybrid Nanoparticles for Drug Delivery."
August 12 2016
Our grant proposal entitled, “HDL-mimetic nanocarriers for miRNA-mediated direct cell reprogramming for vascular regeneration,” was selected from a very competitive group of proposals for the “Georgia Partners in Regenerative Medicine” seed grant program this year. In this project, we collaborate with Dr. Young-sup Yoon at Emory.
February 15 2016
Our project on the targeted delivery of a sonic hedgehog inhibitor for the study of medulloblastoma therapeutics has been featured in ASME.
October 15 2015
Congratulation to Michael and Yoshi! Their review entitled "Nanomedicines for endothelial disorders" has been accepted in Nano Today.
September 21 2015
Our NIH R21 grant proposal entitled "Targeted delivery of a sonic hedgehog inhibitor for the study of medulloblastoma therapeutics" has been awarded. We collaborate with Dr. MacDonald at Emory for the in vivo validation.
July 17 2015
Dr. Kim has been awarded the American Heart Association NCRP Scientist Development Grant on the engineering of anti-miRNA transporting HDL for treating endothelial inflammation in experimental atherosclerosis.
@IBB Kim Grant Targets Atherosclerosis.
May 20 2015
Congratulation to Yoshi Sei. He has been selected as a trainee on the Cell and Tissue Engineering (CTEng) NIH training grant. He works on the development of a microvasculature-on-a-chip device for testing HDL-based drug delivery for the treatment of atherosclerosis.
April 13 2015
Congratulation to Cole Weiler. He has been awarded a President's Undergraduate Research Salary Award (PURA) for Summer 2015. He will be working on characterization of in vitro blood brain barrier model.
March 31 2015
Our grant proposal entitled "Advanced CNS Drug Delivery via Lipoprotein-Polymer Nanocomplexes in Experimental Alzheimer's Disease" has been selected for the Research Class of 2015-2017 in CART (Coins for Alzheimer's Research Trust). We collaborate with Dr. Tansey at Emory for the in vivo validation of the performance of the proposed nanocomplex.
March 13 2015
Congratulation to Yuanda Li! He has been admitted to MIT. He has been working with us on a project entitled "Microfluidic device for platelet activation in response to varying shear rates and hydraulic resistances" since 2014.
March 1 2015
Congratulation to Gevin Reynolds! He has been admitted to Harvard University!!! He worked with us on biomimetic microsystem engineering and control systems engineering in our lab last summer.
October 23 2014
Congratulations to Candice and Yoshi. Our invited Review article entitled "Microengineered vascular systems for drug development" has been accepted in a special issue of Journal of Laboratory Automation.
October 23 2014
Congratulation to Yuanda. He has been awarded a President's Undergraduate Research Salary Award (PURA) for Spring 2015.
October 8 2014
Our grant proposal entitled, “Dominant-negative-TNF-transporting HDL-polymer nanoparticle for treating neuroinflammation associated with Alzheimer’s-like pathology,” has been selected from a very competitive group of proposals for the “Georgia Partners in Regenerative Medicine” seed grant funding this year. In this project, we collaborate with Dr. Tansey at Emory for the in vivo validation of the efficacy of selected nanoparticles.
June 23 2014
We are pleased to announce that Candice Hovell has been awarded the J. Norman and Rosalyn Wells Fellowship in NeuroEngineering. This is a one-time $2500 fellowship award reserved for BME students who are working in neuroengineering, with a preference for those conducting research in brain tumors. Candice works on “Construction of a novel and physiologically relevant in vitro model of the blood brain barrier (BBB) to evaluate the potential of targeted nitric oxide donating molecules as chemotherapeutic adjuvants for the treatment of deep brain tumors”.
June 2 2014
Our grant proposal for the Children's Center for Pediatric Nanomedicine Seed Grant application titled, Engineering Multifunctional Nanoparticles for Acute Myeloid Leukemia has been awarded.
June 1 2014
We welcome Gevin Reynolds as our first high school student into our lab for the summer. We hope you gain invaluable experiences here!
May 1 2014
Dr. Kim has been invited as Distinguished Panel Speaker in the Annual Beckman Scholars and Young Investigators Symposium August 2014. The talk will be entitled “The Fast Pace Progress and Multidisciplinary Approach to Problem Solving: Biomimicry - The New Direction.”
April 20 2014
Congratulations to Candice! She has successfully presented her thesis proposal entitled "Novel In Vitro Platforms for the Study of Glioblastoma Multiforme Therapeutics." She develops a new approach to the blood brain barrier model.
April 15 2014
Congratulations to Candice for her acceptance to the ORISE fellowship at the CDC!
April 1 2014
Candice has received a 2014 NSF Graduate Research Fellowship, based on her outstanding abilities and accomplishments! Congratulations to Candice!
March 1 2014
Yoshi published a good review in Microfluidics and Nanofluidics in January 2014. This is officially the first publication from the Kim Lab at GA Tech! Congratulations!
Our recent work has been featured.
Posted February 4, 2014 | Atlanta, GA
Designing nanomedicine to combat diseases is a hot area of scientific research, primarily for treating cancer, but very little is known in the context of atherosclerotic disease. Scientists have engineered a microchip coated with blood vessel cells to learn more about the conditions under which nanoparticles accumulate in the plaque-filled arteries of patients with atherosclerosis, the underlying cause of myocardial infarction and stroke.